doi: 10.1186/s12951-021-00926-0 87 TangJ.OuyangQ.LiY.ZhangP.JinW.QuS.et al
The systemic (subcutaneous) use described here is unproven and unapproved benefits seen with topical or in-vitro GHK-Cu should not be assumed to transfer to injection, and the safety of injected copper-peptide is not established
also found that the combination of metformin and Diane-35 improved the oestrous cycle disorders, increased the proliferation and differentiation of ovarian FGCs, and inhibited cell apoptosis in PCOS rats
For researchers currently exploring PTD-DBM, this broader momentum provides reassurance that the underlying biological target is widely recognized as valid
When it comes to keratosis pilaris, I tend to recommend products that combine gentle exfoliation with barrier support, rather than anything overly aggressive says Dr Derrick
Ready to go beyond standalone glutathione